BRIEF—Regenerative medicine market anticipated to garner nearly $65 billion sales by 2025

The market for regenerative medicines was valued at $6,677.7 million in 2017, and is expected to reach $64,919.7 million by 2025, registering a compound annual growth rate (CAGR) of 33.05% during the period, 2018-2025, according to Progressive Markets’ new report, titled, Regenerative Medicine Market : Size, Trend, Share, Opportunity Analysis & Forecast, 2016-2025.

The market is driven by the rapid progress in technology for the regeneration of organs and tissues, the growing occurrence of chronic diseases all over the world, the increase in the government and private funding for the development of regenerative diseases, and the growth in geriatric population are causing the industry to grow fast. On the other hand, the high cost of regenerative medicines and stringent government regulations impede the growth of the regenerative medicine market.

The report analyzes the global regenerative medicine market based on type, material, application, and geography. Based on type, the market is classified into tissue engineering, cell therapy, small molecules & biologics, and gene therapy.

The cell therapy segment is likely to grow at a CAGR of 32.74% during the forecast period. The tissue engineering segment is expected to garner $6,825.4 million by 2025. Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics. The synthetic materials segment is expected to garner $22,304.8 million by 2025. Based on application, the market is divided into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The cardiovascular sector is likely to grow at a CAGR of 37.61% and the musculoskeletal segment is likely to grow at a CAGR of 32.44% during the forecast period.